Gastfriend D R, Biederman J, Jellinek M S
Am J Psychiatry. 1984 Jul;141(7):906-8. doi: 10.1176/ajp.141.7.906.
Twelve adolescents with attention deficit disorder were treated with desipramine in an open trial to assess its efficacy and safety. Eleven patients improved within 1 month, and improvement was sustained for 6-12 months without significant adverse effects in nine patients.
对12名患有注意力缺陷障碍的青少年进行了一项使用去甲丙咪嗪的开放性试验,以评估其疗效和安全性。11名患者在1个月内病情有所改善,9名患者病情持续改善6至12个月,且无明显不良反应。